Manufacturer of Controlled Substances; Notice of Application, 30165 [E6-7986]
Download as PDF
<![CDATA[
Federal Register / Vol. 71, No. 101 / Thursday, May 25, 2006 / Notices
$7.50 (25 cents per page reproduction
cost) payable to the U.S. Treasury.
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Thomas A. Mariani, Jr.,
Assistant Section Chief, Environmental
Enforcement Section, Environment and
Natural Resources Division.
[FR Doc. 06–4833 Filed 5–24–06; 8:45 am]
Manufacturer of Controlled
Substances; Notice of Registration
BILLING CODE 4410–15–M
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled
Substances; Notice of Application
cchase on PROD1PC60 with NOTICES
Pursuant to § 1301.33(a) of Title 21 of
the Code of Federal Regulations (CFR),
this is notice that on January 2, 2006,
Applied Science Labs., Division of
Alltech Associates Inc., 2701 Carolean
Industrial Drive, State College,
Pennsylvania 16801, made application
by letter to the Drug Enforcement
Administration (DEA) to be registered as
a bulk manufacturer of
Tetrahydrocannabinols (7370), a basic
class of controlled substance listed in
Schedules I.
The company plans to manufacture
metabolites of Delta–9–THC to be used
as chromatographic standards. These
compounds fall under drug code 7370
(Tetrahydrocannabinols)
Any other such applicant and any
person who is presently registered with
DEA to manufacture such a substance
may file comments or objections to the
issuance of the proposed registration
pursuant to 21 CFR 1301.33(a).
Any such written comments or
objections being sent via regular mail
may be addressed, in quintuplicate, to
the Deputy Assistant Administrator,
Office of Diversion Control, Drug
Enforcement Administration,
Washington, DC 20537, Attention: DEA
Federal Register Representative, Liaison
and Policy Section (ODL); or any being
sent via express mail should be sent to
DEA Headquarters, Attention: DEA
Federal Register Representative/ODL,
2401 Jefferson-Davis Highway,
Alexandria, Virginia 22301; and must be
filed no later than July 24, 2006.
Dated: May 17, 2006.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. E6–7986 Filed 5–24–06; 8:45 am]
BILLING CODE 4410–09–P
VerDate Aug<31>2005
16:42 May 24, 2006
Jkt 208001
By Notice dated January 11, 2006, and
published in the Federal Register on
January 23, 2006, (71 FR 3545), Clariant
LSM (Missouri), Inc., 2460 W. Bennett
Street (or P.O. Box 1246, Zip: 65801),
Springfield, Missouri 65807–1229, made
application by letter to the Drug
Enforcement Administration (DEA) to
be registered as a bulk manufacturer of
Phenylacetone (8501), and Methadone
Intermediate (9254), basic classes of
controlled substances listed in
Schedules II:
The company plans to manufacture in
bulk, for sale to its customers.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and
determined that the registration of
Clariant LSM (Missouri) to manufacture
the listed basic classes of controlled
substances is consistent with the public
interest at this time. DEA has
investigated Clariant LSM (Missouri) to
ensure that the company’s registration is
consistent with the public interest. The
investigation has included inspection
and testing of the company’s physical
security systems, verification of the
company’s compliance with state and
local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 823,
and in accordance with 21 CFR 1301.33,
the above named company is granted
registration as a bulk manufacturer of
the basic classes of controlled
substances listed.
Dated: May 17, 2006.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. E6–7980 Filed 5–24–06; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances;
Notice of Registration
By Notice dated January 11, 2006 and
published in the Federal Register on
January 23, 2006, (71 FR 3545), Clinical
Trial Services (US), 2661 Audubon
Road, Audubon, Pennsylvania 19403,
made application by renewal to the
Drug Enforcement Administration
(DEA) to be registered as an importer of
Fentanyl (9801) and Oxycodone (9143),
PO 00000
Frm 00053
Fmt 4703
Sfmt 4703
30165
basic classes of controlled substances
listed in Schedule II.
The company plans to import small
quantities of the listed controlled
substances in dosage form to conduct
clinical trials.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. Sections 823(a) and
952(a) and determined that the
registration of Clinical Trial Services
(US) to import the basic class of
controlled substances is consistent with
the public interest and with United
States obligations under international
treaties, conventions, or protocols in
effect on May 1, 1971, at this time. DEA
has investigated Clinical Trial Services
(US) to ensure that the company’s
registration is consistent with the public
interest. The investigation has included
inspection and testing of the company’s
physical security systems, verification
of the company’s compliance with state
and local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C.
Sections 952(a) and 958(a), and in
accordance with 21 CFR 1301.34, the
above named company is granted
registration as an importer of the basic
class of controlled substances listed.
Dated: May 18, 2006.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. E6–7981 Filed 5–24–06; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances;
Notice of Registration
By Notice dated February 16, 2006
and published in the Federal Register
on February 24, 2006, (71 FR 9606), JFC
Technologies, LLC., 100 West Main
Street, P.O. Box 669, Bound Brook, New
Jersey 08805, made application by
renewal to the Drug Enforcement
Administration (DEA) to be registered as
an importer of Meperidine intermediateB (9233), a basic class of controlled
substance listed in Schedule II.
The company plans to import the
basic class of controlled substance for
the production of controlled substances
for distribution to its customers.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and 952(a)
and determined that the registration of
JFC Technologies, LLC to import the
basic class of controlled substances is
E:\FR\FM\25MYN1.SGM
25MYN1
]]>Agencies
[Federal Register Volume 71, Number 101 (Thursday, May 25, 2006)]
[Notices]
[Page 30165]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E6-7986]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Application
Pursuant to Sec. 1301.33(a) of Title 21 of the Code of Federal
Regulations (CFR), this is notice that on January 2, 2006, Applied
Science Labs., Division of Alltech Associates Inc., 2701 Carolean
Industrial Drive, State College, Pennsylvania 16801, made application
by letter to the Drug Enforcement Administration (DEA) to be registered
as a bulk manufacturer of Tetrahydrocannabinols (7370), a basic class
of controlled substance listed in Schedules I.
The company plans to manufacture metabolites of Delta-9-THC to be
used as chromatographic standards. These compounds fall under drug code
7370 (Tetrahydrocannabinols)
Any other such applicant and any person who is presently registered
with DEA to manufacture such a substance may file comments or
objections to the issuance of the proposed registration pursuant to 21
CFR 1301.33(a).
Any such written comments or objections being sent via regular mail
may be addressed, in quintuplicate, to the Deputy Assistant
Administrator, Office of Diversion Control, Drug Enforcement
Administration, Washington, DC 20537, Attention: DEA Federal Register
Representative, Liaison and Policy Section (ODL); or any being sent via
express mail should be sent to DEA Headquarters, Attention: DEA Federal
Register Representative/ODL, 2401 Jefferson-Davis Highway, Alexandria,
Virginia 22301; and must be filed no later than July 24, 2006.
Dated: May 17, 2006.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. E6-7986 Filed 5-24-06; 8:45 am]
BILLING CODE 4410-09-P
